226069-56-3

Upstream product

• 226069-54-1 (1R,2R,3S,4R,5R)-4-Benzyloxy-3-methoxy-2-(4-methoxy-phenoxy)-6,8-dioxa-bicyclo[3.2.1]octane 
• 6167-32-4 1,6:3,4-dianhydro-2-O-tosyl-D-galactose 
• 203188-95-8 Toluene-4-sulfonic acid (1R,2S,3S,4R,5R)-3-hydroxy-2-(4-methoxy-phenoxy)-6,8-dioxa-bicyclo[3.2.1]oct-4-yl ester 
• 100-39-0 benzyl bromide 
• 35405-73-3 O³-Methyl-1,6-anhydro-β-D-glucopyranose 

Relevant academic research and scientific papers

GLYCOSAMINOGLYCAN (GAG) MIMETICS

The invention relates to compounds that are designed to mimic the structure of GAGs; methods for the preparation of the compounds; compositions comprising the compounds; and use of the compounds and compositions thereof for the anti-angiogenic, anti-metas

Synthetic oligosaccharides having various functional domains: Potent and potentially safe heparin mimetics

A synthetic heptadecasaccharide, comprising an antithrombin III binding domain, a thrombin binding domain, and a neutral methylareal hexasaccharide sequence, was obtained through a convergent synthesis. This compound displayed in vitro anticoagulant properties similar to that of standard heparin but, in contrast with heparin, escaped neutralization by platelet factor 4, a protein released by activated platelets.